Health Catalyst reported a 9% increase in total revenue for Q4 2023, reaching $75.1 million, and a significant improvement in Adjusted EBITDA to $1.4 million. The company also announced leadership changes, with a new CFO and COO effective March 1, 2024.
Total revenue increased by 9% year-over-year for the quarter ended December 31, 2023, reaching $75.1 million.
Adjusted EBITDA improved significantly to $1.4 million, a 324% increase compared to the same quarter last year.
Leadership changes were announced, including a new CFO and COO, effective March 1, 2024.
Full year 2023 revenue reached $295.9 million, and Adjusted EBITDA was $11.0 million.
Health Catalyst provides forward-looking guidance on total revenue and Adjusted EBITDA for the first quarter and full year of 2024.
Visualization of income flow from segment revenue to net income